drugset
drugset / Trial / NCT06925607

Evaluate the Distribution and Dynamic Behavior of Nuclide Labeled TH-SC01 Cells in Vivo in Patients With Radiation Proctitis

NCT06925607 ↗

Phase 1 Not yet recruiting 6 enrolled Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
RandomizedSingle-groupOpen-labelTreatment

Summary

A Phase l clinical study evaluating the distribution and dynamic behavior of Nuclide labeled TH-SC01 cells in vivo in patients with Radiation proctitis

Timeline

Start
2025-04
Primary completion
2026-03
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject TH-SC01 Cell therapy 1.2e+08 cells —

Indications

radiation proctitis